We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Appeals Court Sides With AbbVie in Humira ‘Patent Thicket’ Antitrust Suit
Appeals Court Sides With AbbVie in Humira ‘Patent Thicket’ Antitrust Suit
A U.S. appeals court panel has said no to resurrecting a 2019 lawsuit alleging that AbbVie broke antitrust laws by using a “patent thicket” to cover its blockbuster monoclonal antibody Humira from copycat drugs coming to market, thus exploiting the patent system.